Advertisement
Section edited by Jean-Claude Desenclos
This section aims to publish studies looking at all aspects of the prevention, diagnosis and management of hepatitis in humans as well as related molecular genetics, pathophysiology, and epidemiology
Research article
Hepatitis A virus (HAV) infection is endemic in Eastern European and Balkan region countries. In 2012, Bulgaria showed the highest rate (67.13 cases per 100,000) in Europe. Nevertheless, HAV genotypes and stra...
BMC Infectious Diseases 2017 17:497
Published on: 14 July 2017
Research article
Hepatitis E is self-limiting, but can cause death in most at risk groups like pregnant women and those with preexisting acute liver disease. In developing countries it presents as epidemic, in 2014 Hepatitis E...
BMC Infectious Diseases 2017 17:451
Published on: 26 June 2017
Research article
Treatment for chronic hepatitis B (CHB) is virtually absent in sub-Saharan Africa. Here we present early experiences from a pilot program for treatment of CHB in Ethiopia.
BMC Infectious Diseases 2017 17:438
Published on: 19 June 2017
Research article
The aims of this analysis were to investigate treatment completion and adherence among people with ongoing injecting drug use or receiving opioid substitution therapy (OST) in a study of response-guided therap...
BMC Infectious Diseases 2017 17:420
Published on: 13 June 2017
Research article
Viral Hepatitis B is of a major public health concern globally, especially in developing countries. Expectant mothers’ knowledge of Mother-To-Child Transmission (MTCT) of the disease is significant in preventi...
BMC Infectious Diseases 2017 17:416
Published on: 12 June 2017
Research article
This Phase 3, open-label, rollover study (NCT01323244) investigated the efficacy and safety of simeprevir plus peginterferon α-2a (PegIFNα-2a) and ribavirin (RBV) in a well-characterized population of HCV geno...
BMC Infectious Diseases 2017 17:389
Published on: 2 June 2017
Research article
There is a need for validation of noninvasive alternatives to liver biopsy for the evaluation of fibrosis in children with chronic hepatitis C (CHC). The aim of this study was to evaluate the diagnostic perfor...
BMC Infectious Diseases 2017 17:361
Published on: 23 May 2017
Research article
In Japan, approximately 0.9% and 1% of the whole population are infected with HBV and HCV, respectively. Doctors from departments other than gastroenterology often order viral hepatitis tests before an invasiv...
BMC Infectious Diseases 2017 17:330
Published on: 8 May 2017
Research article
Hepatitis C virus (HCV) infections have increased during the past decade but little is known about geographic clustering patterns.
BMC Infectious Diseases 2017 17:294
Published on: 20 April 2017
Research article
Hepatitis C infection is a major public health concern in low- and middle-income countries where an estimated 71.1 million individuals are living with chronic infection. The World Health Organization (WHO) has...
BMC Infectious Diseases 2017 17:260
Published on: 11 April 2017
Research article
In chronic hepatitis C, the fibrosis progression rates are extremely variable and can be influenced by factors associated with the host, virus and environment. Among the associated metabolic factors, hepatic s...
BMC Infectious Diseases 2017 17:235
Published on: 29 March 2017
Research article
Hepatitis C virus (HCV) infection is a pandemic causing disease; more than 185 million people are infected worldwide. An HCV antibody (Ab) prevalence of 6.0% was estimated in Central African countries. The stu...
BMC Infectious Diseases 2017 17:167
Published on: 22 February 2017
Research article
HCV transmission remains high in people who inject drugs (PWID) in Montréal. New direct-acting antivirals (DAAs), highly effective and more tolerable than previous regimens, make a “Treatment as Prevention” (T...
BMC Infectious Diseases 2017 17:162
Published on: 21 February 2017
Research article
The sodium taurocholate co-transporting polypeptide, encoded by SLC10A1, was identified as a functional receptor for hepatitis B virus (HBV). The objective of this study was to determine if there was an associ...
BMC Infectious Diseases 2017 17:99
Published on: 26 January 2017
Research article
Cocaine and crack use has been associated with HIV and HCV infections, but its consequences on HCV progression have not been well established. We analyzed the impact of cocaine/crack use on liver fibrosis prog...
BMC Infectious Diseases 2017 17:80
Published on: 17 January 2017
Research article
Toll like receptors (TLRs) play an important role in innate immunity and various studies suggest that TLRs play a crucial role in pathogenesis of hepatitis B virus (HBV) infection. The present study aims in lo...
BMC Infectious Diseases 2017 17:76
Published on: 14 January 2017
Research article
There is limited evidence for the effectiveness of daclatasvir in patients whose hepatitis C threatens their life expectancy. The Named Patient Program in Europe included patients with advanced chronic hepatit...
BMC Infectious Diseases 2017 17:45
Published on: 7 January 2017
Research article
Rwanda is a central African country with about 12 million inhabitants. The 1994 genocide against the Tutsi destroyed much of the infrastructure, including the health system. Although this has improved signific...
BMC Infectious Diseases 2017 17:32
Published on: 6 January 2017
Research article
The concentrations of hepatitis B virus (HBV) DNA and surface antigen (HBsAg) are two critical virological variables to be monitored in chronic hepatitis B. HBsAg is derived from the HBV genome. Thus, higher H...
BMC Infectious Diseases 2017 17:9
Published on: 5 January 2017
Research article
The existing seroepidemiological data on viral hepatitis in Ethiopia showed a wide variation in prevalence pattern and the clinical and public health burden have been underestimated. The aim of this systematic...
BMC Infectious Diseases 2016 16:761
Published on: 19 December 2016
The Erratum to this article has been published in BMC Infectious Diseases 2017 17:114
